Honasa Consumer to buy 58% stake in Fluence Pharma at Rs 135-crore enterprise value
Published on: June 24, 2026, 1:16 a.m. | Source: The Economic Times
Mamaearth's parent company, Honasa Consumer, is acquiring a majority stake in nutraceuticals brand Fluence Pharma for ₹135 crore. This strategic move, Honasa's second acquisition in under a year, signals a growing trend of consolidation in the beauty and personal care sector. Honasa aims to integrate science-backed skincare with nutraceuticals, addressing consumer demand for holistic wellness solutions. Fluence Pharma will become the ninth brand under Honasa's umbrella.
